An update on the global trends in the burden of primary liver cancers
- PMID: 37818908
- DOI: 10.1002/jso.27445
An update on the global trends in the burden of primary liver cancers
Abstract
Liver cancer (LC) remains one of the major causes of cancer-related mortality worldwide. The Incidence, mortality, and prevalence associated with primary LCs were analyzed over the past decade, using GLOBOCAN 2012 and 2020, to understand the trends related to geographic and socioeconomic factors. While total cases of primary LCs continue to rise, global rates of LC incidence and mortality are slowing, mostly driven by changes seen in historically endemic regions.
Keywords: GLOBOCAN; Human Development Index; WHO regions.
© 2023 Wiley Periodicals LLC.
Similar articles
-
Global trends in the burden of liver cancer.J Surg Oncol. 2017 Apr;115(5):591-602. doi: 10.1002/jso.24518. Epub 2017 Mar 26. J Surg Oncol. 2017. PMID: 28345140
-
Descriptive epidemiology of incidence and mortality of primary liver cancer in 185 countries: evidence from GLOBOCAN 2018.Jpn J Clin Oncol. 2020 Dec 16;50(12):1370-1379. doi: 10.1093/jjco/hyaa130. Jpn J Clin Oncol. 2020. PMID: 32719873
-
Impact of national Human Development Index on liver cancer outcomes: Transition from 2008 to 2018.World J Gastroenterol. 2019 Aug 28;25(32):4749-4763. doi: 10.3748/wjg.v25.i32.4749. World J Gastroenterol. 2019. PMID: 31528099 Free PMC article.
-
Global Cancer in Women: Burden and Trends.Cancer Epidemiol Biomarkers Prev. 2017 Apr;26(4):444-457. doi: 10.1158/1055-9965.EPI-16-0858. Epub 2017 Feb 21. Cancer Epidemiol Biomarkers Prev. 2017. PMID: 28223433 Review.
-
Global, regional, and national burden of respiratory tract cancers and associated risk factors from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019.Lancet Respir Med. 2021 Sep;9(9):1030-1049. doi: 10.1016/S2213-2600(21)00164-8. Epub 2021 Aug 16. Lancet Respir Med. 2021. PMID: 34411511 Free PMC article.
Cited by
-
Prognostic predictive value of the preoperative systemic immunoinflammatory index combined with the neutrophil-to-lymphocyte ratio in patients with primary liver cancer undergoing transarterial chemoembolization.Oncol Lett. 2025 Jun 27;30(3):414. doi: 10.3892/ol.2025.15160. eCollection 2025 Sep. Oncol Lett. 2025. PMID: 40630711 Free PMC article.
-
Hepatoblastoma regional trends: dynamic SDI & joinpoint regression analysis.BMC Cancer. 2025 Jul 5;25(1):1148. doi: 10.1186/s12885-025-14566-2. BMC Cancer. 2025. PMID: 40618033 Free PMC article.
References
REFERENCES
-
- Llovet JM, Kelley RK, Villanueva A, et al. Hepatocellular carcinoma. Nat Rev Dis Primers. 2021;7:6. doi:10.1038/s41572-020-00240-3
-
- Yanala U, Malhotra G, Are C, Padussis J. Intrahepatic cholangiocarcinoma: rising burden and glaring disparities. Ann Surg Oncol. 2019;26:1979-1980. doi:10.1245/s10434-019-07176-3
-
- Arzumanyan A, Reis HMGPV, Feitelson MA. Pathogenic mechanisms in HBV- and HCV-associated hepatocellular carcinoma. Nat Rev Cancer. 2013;13:123-135. doi:10.1038/nrc3449
-
- Huang DQ, Singal AG, Kono Y, Tan DJH, El-Serag HB, Loomba R. Changing global epidemiology of liver cancer from 2010 to 2019: NASH is the fastest growing cause of liver cancer. Cell Metab. 2022;34:969-977.e2. doi:10.1016/j.cmet.2022.05.003
-
- Are C, Meyer B, Stack A, et al. Global trends in the burden of liver cancer. J Surg Oncol. 2017;115:591-602. doi:10.1002/jso.24518
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous